Articles | Volume 6, issue 4
https://doi.org/10.5194/jbji-6-91-2021
https://doi.org/10.5194/jbji-6-91-2021
Original full-length article
 | 
27 Jan 2021
Original full-length article |  | 27 Jan 2021

One-year infection control rates of a DAIR (debridement, antibiotics and implant retention) procedure after primary and prosthetic-joint-infection-related revision arthroplasty – a retrospective cohort study

F. Ruben H. A. Nurmohamed, Bruce van Dijk, Ewout S. Veltman, Marrit Hoekstra, Rob J. Rentenaar, Harrie H. Weinans, H. Charles Vogely, and Bart C. H. van der Wal

Related authors

Long-term outcome of two-stage revision surgery after hip and knee prosthetic joint infections: an observational study
Yorrick P. Bourgonjen, J. Fred F. Hooning van Duyvenbode, Bruce van Dijk, F. Ruben H. A. Nurmohamed, Ewout S. Veltman, H. Charles Vogely, and Bart C. H. van der Wal
J. Bone Joint Infect., 6, 379–387, https://doi.org/10.5194/jbji-6-379-2021,https://doi.org/10.5194/jbji-6-379-2021, 2021
Short summary

Related subject area

Subject: Prosthesis-related infections | Topic: Surgery
Fluorescent tetracycline bone labeling as an intraoperative tool to debride necrotic bone during septic hip revision: a preliminary case series
Ernesto Muñoz-Mahamud, Jenaro Ángel Fernández-Valencia, Andreu Combalia, Laura Morata, and Álex Soriano
J. Bone Joint Infect., 6, 85–90, https://doi.org/10.5194/jbji-6-85-2021,https://doi.org/10.5194/jbji-6-85-2021, 2021
Short summary

Cited articles

Ahmed, S. S., Yaghmour, K. M., and Haddad, F. S.: The Changing Face of Infection, Diagnosis, and Management in the United Kingdom, Orthop. Clin. North Am., 51, 141–146, https://doi.org/10.1016/j.ocl.2019.12.003, 2020. 
Barrett, L. and Atkins, B.: The clinical presentation of prosthetic joint infection, J. Antimicrob. Chemother., 69, 25–28, https://doi.org/10.1093/jac/dku250, 2014. 
Byren, I., Bejon, P., Atkins, B. L., Angus, B., Masters, S., Gundle, R., Berendt, A., Unit, B. I., Centre, N. O., Road, W., Ox, O., Hospital, J. R., Way, H., Ox, H., Hospital, J. R., Way, H., and Ox, H.: One hundred and twelve infected arthroplasties treated with “DAIR” (debridement, antibiotics and implant retention): antibiotic duration and outcome, J. Antimicrob. Chemother., 63, 1264–1271, https://doi.org/10.1093/jac/dkp107, 2009. 
Chalmers, B. P., Weston, J. T., Hanssen, A. D., Berry, D. J., Abdel, M. P., and Osmon, D. R.: Prior hip or knee prosthetic joint infection in another joint increases risk three-fold of prosthetic joint infection after primary total knee arthroplasty: A matched control study, Bone Jt. J., 101, 91–97, https://doi.org/10.1302/0301-620X.101B7.BJJ-2018-1189.R1, 2019. 
Chotanaphuti, T., Courtney, P. M., Fram, B., In den Kleef, N. J., Kim, T. K., Kuo, F. C., Lustig, S., Moojen, D. J., Nijhof, M., Oliashirazi, A., Poolman, R., Purtill, J. J., Rapisarda, A., Rivero-Boschert, S., and Veltman, E. S.: Hip and Knee Section, Treatment, Algorithm: Proceedings of International Consensus on Orthopedic Infections, J. Arthroplasty, 34, S393–S397, https://doi.org/10.1016/j.arth.2018.09.024, 2019. 
Download
Short summary
Literature reporting on the effectiveness of DAIR (debridement, antibiotics and implant retention) procedures performed after a one- or two-stage revision because of a prosthetic joint infection (PJI-related revision arthroplasty) is scarce. Infection control rates of a DAIR procedure after primary arthroplasty (n = 51) and after prior PJI-related revision arthroplasty (n = 16) were 69 % and 56 %, respectively. No statistically significant difference is found in infection control after 1 year.